Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optokinetic Stimulation for the Treatment of Hemispatial Neglect - Safety and Efficacy Studies

NCT03451708 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT03451708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03451708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optokinetic Stimulation for the Treatment of Hemispatial Neglect - Safety and Efficacy Studies
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Overall status
Withdrawn
Start date
May 1, 2018
Completion date
March 31, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neglect, hemisensory, neglect, hemispatial, neglect, sensory